Market Cap
$2.9B
ATRC
AtriCure, Inc.
$55.14 ▲ +2.89%
Prev close $53.59Market cap$2.9B
ConsensusStrong Buy
12-mo target$54.89 (-0.5%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (3 insiders)34 New Institutional Positions14 Institutional ExitsCongressional Activity (1) Healthcare & Medical Devices
Snapshot
The big-picture read on ATRC right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (81%)
Inst. Holders
50 funds
Inst. Value
$1.2B
Inst. Activity
34 buys / 14 sells
Insider Activity
$0.00 buy / $3.7M sell
Insider Net $
-$3.7M
SEC Reports
10
Congressional
2 trades
Price chart 30d +5.1%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: ATRC — 56.7% short (0.5M / 0.9M)
Short: 483,254 | Exempt: 4,528 | TRF Vol: 851,974 | Short Ratio: 56.7% | Off-exchange volume (dark p
Sep 23, 2026 Insider
Sep 15, 2026 SEC Privitera Salvatore sold 4,519 shares
Chief Technical Officer @ $60.00 ($271.1K)
Two AtriCure insiders — the CTO and a director — sold a combined $489K in open-market sales over an 8-day window. The to
CLUSTER — Impact 2/10
Sep 11, 2026 Insider
GROVES REGINA E sold 5,313 shares
Director @ $54.22 ($288.1K)
Sep 8, 2026 Insider
Privitera Salvatore sold 3,657 shares
Chief Technical Officer @ $55.00 ($201.1K)
Aug 20, 2026 Congress
Aug 7, 2026 SEC Gilbert Cisneros buy
$1,001 - $15,000 — House
Two AtriCure insiders (a Director and the Chief Marketing & Strategy Officer) sold a combined $378K in open-market trans
CLUSTER — Impact 2/10
Three AtriCure insiders sold a total of $1.42M in open-market shares over the past week, representing just 0.075% of the
CLUSTER — Impact 2/10
Analyst ratings buy % -12.9%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
81% rate it Buy or better · 16 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Oct 2, 2026 | Freedom Capital Markets | DOWNGRADE | Hold | 46% |
| Sep 2, 2026 | Needham | MAINTAIN | Buy | 50% |
| Aug 27, 2026 | Piper Sandler | MAINTAIN | Overweight | 54% |
| Aug 24, 2026 | BTIG | MAINTAIN | Buy | 53% |
| Jul 28, 2026 | UBS | MAINTAIN | Buy | 55% |
| May 6, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 9 | 3 | 0 | 0 | 81% | |
| Aug 1, 2026 | 4 | 9 | 3 | 0 | 0 | 81% | |
| Jul 1, 2026 | 4 | 9 | 3 | 0 | 0 | 81% | |
| Jun 1, 2026 | 4 | 9 | 3 | 0 | 0 | 81% | |
| May 1, 2026 | 4 | 9 | 3 | 0 | 0 | 81% | |
| Apr 1, 2026 | 4 | 8 | 3 | 0 | 0 | 80% | |
| Mar 1, 2026 | 4 | 8 | 3 | 0 | 0 | 80% | |
| Feb 1, 2026 | 5 | 9 | 1 | 0 | 0 | 93% |
Price targets
Where 9 covering analysts think ATRC trades over the next 12 months.
$54.89 -0.5% upside Hold
Current$55.14 Low$36.00 Median$55.00 High$65.00 9 analysts
$36.00$65.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
10 SEC filing reports analyzed · 2 bullish, 1 bearish, 1 mixed, 6 neutral · avg impact 3.5/10.
NEUTRALCLUSTER2/10
Two AtriCure insiders — the CTO and a director — sold a combined $489K in open-market sales over an
Sep 15, 2026
NEUTRALCLUSTER2/10
Two AtriCure insiders (a Director and the Chief Marketing & Strategy Officer) sold a combined $378K
Aug 7, 2026
NEUTRALCLUSTER2/10
Three AtriCure insiders sold a total of $1.42M in open-market shares over the past week, representin
Aug 3, 2026
NEUTRALCLUSTER2/10
Three AtriCure insiders (Director, CSO, CMO) sold a total of $1.42M in open-market shares over two d
Jul 31, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: ATRC — 56.7% short (0.5M / 0.9M)
Short: 483,254 | Exempt: 4,528 | TRF Vol: 851,974 | Short Ratio: 56.7% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: ATRC — 56.1% short (0.3M / 0.5M)
Short: 288,616 | Exempt: 162 | TRF Vol: 514,847 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)
Sep 18, 2026
short_volume
Short Volume: ATRC — 70.3% short (0.5M / 0.7M)
Short: 490,566 | Exempt: 7,439 | TRF Vol: 698,150 | Short Ratio: 70.3% | Off-exchange volume (dark pool + OTC)
Sep 17, 2026
short_volume
Short Volume: ATRC — 63.0% short (0.4M / 0.6M)
Short: 394,457 | Exempt: 2,417 | TRF Vol: 626,424 | Short Ratio: 63.0% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_volume
Short Volume: ATRC — 71.6% short (0.4M / 0.6M)
Short: 405,488 | Exempt: 2,500 | TRF Vol: 566,421 | Short Ratio: 71.6% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.01 | $-0.03–$0.05 | 219.2% | +0.0% | 2↑ 5↓ | $0.2B | 9 |
| Next Q | $0.09 | $0.04–$0.13 | 46.3% | +0.0% | 4↑ 2↓ | $0.2B | 9 |
| Current FY | $0.28 | $0.25–$0.31 | 358.4% | +0.0% | 8↑ 0↓ | $0.6B | 9 |
| Next FY | $0.43 | $0.21–$0.64 | 52.7% | +0.5% | 7↑ 1↓ | $0.7B | 9 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.012 | — |
| 7d ago | $0.012 | — |
| 30d ago | $0.012 | — |
| 60d ago | $0.012 | -0.000 |
| 90d ago | $0.015 | -0.003 |
Institutional ownership
Which big funds own ATRC (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.2B total value (41,635,008 shares) as of 2026-Q2. Top holders: BlackRock,, WELLINGTON, VANGUARD. Net buying activity: 34 institutions added/increased vs 14 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 4,474,548 | $125.2M | 10.7% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 3,495,603 | $97.8M | 8.4% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,127,195 | $87.5M | 7.5% | — |
| Hood River Capital Management LLC | 2,905,299 | $81.3M | 7.0% | — |
| ALLIANCEBERNSTEIN L.P. | 2,768,365 | $79.0M | 6.8% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,190,413 | $61.3M | 5.3% | — |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1,734,279 | $48.5M | 4.2% | — |
| GOLDMAN SACHS GROUP INC | 1,597,988 | $44.7M | 3.8% | — |
| STATE STREET CORP | 1,389,989 | $38.9M | 3.3% | — |
| MARSHALL WACE, LLP | 1,333,904 | $37.3M | 3.2% | ADD +60.7% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 277,682 | 1,296,209 | +366.8% | $36.3M |
| Point72 Asset Management, L.P. | NEW | — | 604,380 | — | $16.9M |
| FMR LLC | ADD | 336,814 | 506,357 | +50.3% | $14.2M |
| MORGAN STANLEY | TRIM | 719,162 | 457,798 | -36.3% | $12.8M |
| PANAGORA ASSET MANAGEMENT INC | ADD | 227,377 | 389,099 | +71.1% | $10.9M |
| NORGES BANK | NEW | — | 374,362 | — | $10.5M |
| D. E. Shaw & Co., Inc. | DOUBLED | 56,589 | 192,824 | +240.7% | $5.4M |
| CITADEL ADVISORS LLC | DOUBLED | 87,347 | 177,339 | +103.0% | $5.0M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | NEAR_EXIT | 555,114 | 131,853 | -76.2% | $3.7M |
| WELLS FARGO & COMPANY/MN | ADD | 69,084 | 104,743 | +51.6% | $2.9M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
15 insiders, 50 transactions. Net -$3.7M — $0.00 bought, $3.7M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Privitera Salvatore | Chief Technical Officer | SELL | 4,519 | $60.00 | $271.1K |
| Sep 11, 2026 | GROVES REGINA E | Director | SELL | 5,313 | $54.22 | $288.1K |
| Sep 8, 2026 | Privitera Salvatore | Chief Technical Officer | SELL | 3,657 | $55.00 | $201.1K |
| Sep 2, 2026 | Privitera Salvatore | Chief Technical Officer | SELL | 7,763 | $52.50 | $407.6K |
| Aug 24, 2026 | Dahlquist Karl S. | Chief Legal Officer | SELL | 9,370 | $48.89 | $458.1K |
| Aug 5, 2026 | Prange Karen | Director | SELL | 3,564 | $38.80 | $138.3K |
| Aug 5, 2026 | Yuen Maggie | Director | SELL | 3,500 | $38.42 | $134.5K |
| Jul 30, 2026 | CARREL MICHAEL H | President, CEO, & Director | GIFT | 700 | — | — |
| Jul 30, 2026 | CARREL MICHAEL H | President, CEO, & Director | GIFT | 4,000 | — | — |
| Jul 29, 2026 | Noznesky Justin J | Chief Mktg & Strategy Officer | SELL | 6,182 | $38.80 | $239.9K |
Congressional trades
ATRC trades disclosed by members of Congress, with disclosure delay.
1 members · 2 buys / 0 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | AtriCure Inc | Sep 11, 2026(23d) |
| Mar 3, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | AtriCure Inc | Apr 8, 2026(37d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ATRC.
Shares short
4,279,518
Settlement Sep 15, 2026
Change vs prior
+3.3%
Semi-monthly cycle
Days to cover
3.6
At avg daily volume
Of shares outstanding
≈8.4%
Estimate — not % of float
All ATRC filing & press-release reports (10)
- CLUSTER reportSep 15, 2026
- CLUSTER reportAug 7, 2026
- CLUSTER reportAug 3, 2026
- CLUSTER reportJul 31, 2026
- 8-K reportJul 23, 2026
- INST-CLUSTER reportJun 14, 2026
- INST-CLUSTER reportJun 11, 2026
- CLUSTER reportMay 22, 2026
- 8-K reportMay 5, 2026
- DEFA14A reportApr 6, 2026